People searching "is GHRP-6 legal" usually run into three different claims at once: it is "not approved," it is sold "for research use only," and it is "banned." Those are separate questions, answered by separate authorities. This article pulls them apart for one compound. For what GHRP-6 is and what the research shows, see the GHRP-6 profile. For the wider picture across all peptides, see Are Peptides Legal?.
Four questions that often get mixed up
1. Medicine approval
In the US, approval means FDA has reviewed a drug for a specific use. FDA says unapproved prescription drugs have not been reviewed for safety, effectiveness or quality. "Not approved" is a statement about that record. On its own, it does not tell you what happens to a buyer, a seller, or an athlete.
2. Prescribing and compounding
Compounding is when a pharmacy or an FDA-registered outsourcing facility makes a custom drug. Federal law limits which raw ingredients ("bulk drug substances") they can use. Pharmacies work under section 503A of the Food, Drug, and Cosmetic Act. Outsourcing facilities work under section 503B. While FDA builds its official lists, it sorts nominated ingredients into three categories. Its interim policy of not taking action covers only Category 1. Category 2 means FDA found significant safety risks. Category 3 means the nomination lacked enough support to evaluate.
3. "Research use only" labels
This is wording a seller chooses to print. It is not a license, a category FDA grants on request, or a safety rating. US rules do describe a narrow lane for shipping a new drug solely for lab tests in test tubes or in lab animals. That lane requires a set caution statement, due diligence that the buyer really runs such tests, and shipment records (21 CFR 312.160). Printing a disclaimer is not the same as meeting those conditions.
4. Anti-doping rules
WADA's Prohibited List is a rule set for sport, not a national law. It lists substances athletes may not use under anti-doping programs that follow the World Anti-Doping Code. A substance can be on this list whether or not it is legal to buy where you live.
What we found for GHRP-6
| Authority / jurisdiction | Issue | Finding | Effective / checked date | Source |
|---|---|---|---|---|
| US FDA (drug approvals) | Is there an FDA-approved drug containing GHRP-6? | None found. A search of FDA's Drugs@FDA data returned no product listing GHRP-6 as an active ingredient. The same search did find macimorelin, an approved drug from the same broad class, so the search itself worked. | Data updated 2026-09-14 · checked 2026-09-15 | openFDA Drugs@FDA |
| US FDA (compounding, section 503B) | Can outsourcing facilities use GHRP-6 under FDA's interim policy? | No. GHRP-6 is in 503B Category 2, "significant safety risks." Category 2 is outside the interim policy, which covers Category 1. | Added 2023-09-29 · FDA page current as of 2026-04-22 · checked 2026-09-15 | FDA Category 2 safety risks page |
| US FDA (compounding, section 503A) | Is GHRP-6 in the group FDA's pharmacy interim policy covers? | No. GHRP-6 is in 503A Category 3, "nominated without adequate support." It is not in Category 1. | FDA list updated 2026-05-14 · checked 2026-09-15 | FDA 503A categories list |
| US FDA (sale labeling) | Does a "research use only" disclaimer settle how FDA views a product? | No. FDA judges a product's intended use from objective evidence such as claims, advertising and the circumstances of sale (21 CFR 201.128). A disclaimer is one piece of that evidence, not the deciding one. | Regulation text current to 2026-09-11 · checked 2026-09-15 | 21 CFR 201.128 |
| WADA (sport, international) | Is GHRP-6 prohibited in sport? | Yes. Named in section S2.2.4 (growth hormone releasing factors). Prohibited at all times, in and out of competition. All S2 substances are "non-Specified." | 2026 List, in effect from 2026-01-01 · checked 2026-09-15 | WADA Prohibited List |
What a "research only" label does and does not establish
What the label can tell you
- The seller is not presenting the product as an approved medicine
- The seller wants to avoid making direct claims about human use
- Nobody has claimed FDA reviewed this product for people
What the label does not establish
- That GHRP-6 is FDA-approved (we found no approved drug)
- That selling it for human use is lawful (FDA looks at the whole context, not the disclaimer)
- That the vial contains what it says, at the stated purity, or is sterile
- That the seller meets the lab-research shipping rules in 21 CFR 312.160
- That it is allowed in sport (WADA's list applies regardless of the label)
For the wider pattern of how these labels are used across the market, see Research Peptides: The "Not for Human Use" Label.
"Not approved," "illegal" and "prohibited in sport" are different conclusions
- Not approved is a fact about FDA's records. For GHRP-6 in the US, we found no approved drug.
- Illegal depends on who does what, and where. Selling, compounding and owning are not the same act, and the rules above show they can be treated differently. We did not verify rules on personal possession, state law, or importing, so this page does not say that owning GHRP-6 is a crime.
- Prohibited in sport is a WADA rule for athletes in anti-doping programs. It applies whether a product was bought legally or not. WADA notes that athletes are responsible for any substance that enters their body.
Anti-doping scientists have published lab methods to detect GHRP-6 and related peptides in urine, so this is not a rule that exists only on paper.
Evidence and safety: what is still uncertain
The human research on GHRP-6 is small and mostly short-term. Examples include a single-dose drug-level study in nine healthy men, and a study in 10 patients with Cushing's disease showing GHRP-6 raised the stress hormones ACTH and cortisol. These were hospital or lab tests, not long-term trials of benefit or safety.
FDA's own summary, written for compounding, says it found limited safety information. It flags possible effects on cortisol, a rise in blood sugar linked to lower insulin sensitivity, and a risk of immune reactions for some routes because peptides can clump and carry impurities. None of that tells anyone how to use GHRP-6 safely, and this site does not give use guidance.
What about other countries?
This page does not survey other countries. Medicine rules differ by country, so check your own national regulator. WADA's list works differently: it is one international standard used by anti-doping programs that follow the World Anti-Doping Code, so the GHRP-6 entry does not change from country to country. Our broad legal guide explains the general landscape, and the Safety & Regulation section collects related explainers.
What this does not mean
- This does not mean owning GHRP-6 is a crime. We did not verify possession, state, or import rules.
- This does not mean GHRP-6 is safe or unsafe at any amount. Human safety data are limited, and we give no use guidance.
- This does not cover countries other than the US, except for WADA's sport rules.
- This is general education checked on September 15, 2026, not legal advice. Rules and FDA lists change.